Lipid Mediators: Lipoxin and Aspirin-Triggered 15-Epi-Lipoxins

E-ISSN： 2212-4055|5|2|81-90

ISSN： 1871-5281

Source： Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol.5, Iss.2, 2006-04, pp. : 81-90

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Nitric Oxide, Aspirin-Triggered Lipoxins and NO-Aspirin in Gastric Protection

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 5, Iss. 2, 2006-04 ,pp. : 133-137

Bentham Science Publishers

Access to resources Recommend Favorite

Lipoxins, The Novel Mediators of Gastroprotection and Gastric Adaptation to Ulcerogenic action of Aspirin

Current Pharmaceutical Design, Vol. 17, Iss. 16, 2011-06 ,pp. : 1541-1551

Bentham Science Publishers

Access to resources Recommend Favorite

Lipid Mediators in Inflammatory Disorders

By Heller A.

Drugs, Vol. 55, Iss. 4, 1998-04 ,pp. : 487-496

Adis International

Access to resources Recommend Favorite

Lipoxins: revelations on resolution

By McMahon B. Mitchell S. Brady H.R. Godson C.

Trends in Pharmacological Sciences, Vol. 22, Iss. 8, 2001-08 ,pp. : 391-395

Elsevier

Access to resources Recommend Favorite

Endocannabinoids: A New Family of Lipid Mediators Involved in the Regulation of Neural Cell Development

Current Pharmaceutical Design, Vol. 12, Iss. 18, 2006-06 ,pp. : 2319-2325

Bentham Science Publishers

Access to resources Recommend Favorite